[Pharmacological management of cerebral palsy--focused on botulinum toxin therapy].
Nezu
A
A
anezu@urahp.yokohama-cu.ac.jp
Osawa
M
M
D001905:Botulinum Toxins / Q000008:administration & dosage / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D015201:Meta-Analysis as Topic; D017410:Practice Guidelines as Topic; D012720:Severity of Illness Index
D001905:Botulinum Toxins